Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Smoke in the operating room.
Righini CA, Fabre C. Righini CA, et al. Among authors: fabre c. Eur Ann Otorhinolaryngol Head Neck Dis. 2024 Feb 27:S1879-7296(24)00027-9. doi: 10.1016/j.anorl.2024.02.010. Online ahead of print. Eur Ann Otorhinolaryngol Head Neck Dis. 2024. PMID: 38418355 No abstract available.
Detection and severity quantification of pulmonary embolism with 3D CT data using an automated deep learning-based artificial solution.
Djahnine A, Lazarus C, Lederlin M, Mulé S, Wiemker R, Si-Mohamed S, Jupin-Delevaux E, Nempont O, Skandarani Y, De Craene M, Goubalan S, Raynaud C, Belkouchi Y, Afia AB, Fabre C, Ferretti G, De Margerie C, Berge P, Liberge R, Elbaz N, Blain M, Brillet PY, Chassagnon G, Cadour F, Caramella C, Hajjam ME, Boussouar S, Hadchiti J, Fablet X, Khalil A, Talbot H, Luciani A, Lassau N, Boussel L. Djahnine A, et al. Among authors: fabre c. Diagn Interv Imaging. 2024 Mar;105(3):97-103. doi: 10.1016/j.diii.2023.09.006. Epub 2023 Oct 11. Diagn Interv Imaging. 2024. PMID: 38261553
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
Bauer TM, Santoro A, Lin CC, Garrido-Laguna I, Joerger M, Greil R, Spreafico A, Yau T, Goebeler ME, Hütter-Krönke ML, Perotti A, Juif PE, Lu D, Barys L, Cremasco V, Pelletier M, Evans H, Fabre C, Doi T. Bauer TM, et al. Among authors: fabre c. J Immunother Cancer. 2023 Nov 29;11(11):e007353. doi: 10.1136/jitc-2023-007353. J Immunother Cancer. 2023. PMID: 38030303 Free PMC article. Clinical Trial.
Multiple Sustainable Benefits of a Rehabilitation Program in Therapeutic Management of Hypermobile Ehlers-Danlos Syndrome: A Prospective and Controlled Study at Short- and Medium-Term.
Hakimi A, Bergoin C, De Jesus A, Hoorelbeke A, Ramon P, Florea O, Fabre C, Mucci P. Hakimi A, et al. Among authors: fabre c. Arch Phys Med Rehabil. 2023 Dec;104(12):2059-2066. doi: 10.1016/j.apmr.2023.06.012. Epub 2023 Jul 4. Arch Phys Med Rehabil. 2023. PMID: 37406924 Clinical Trial.
401 results